Spots Global Cancer Trial Database for cystectomy
Every month we try and update this database with for cystectomy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Phase 0 of Neoadjuvant Lapatinib in Infiltrative Bladder Carcinoma Before Cystectomy | NCT01245660 | Bladder Carcino... Infiltrative Bl... Cystectomy | LAPATINIB | 18 Years - | University Hospital, Bordeaux | |
| Tranexamic Acid During Cystectomy Trial (TACT) | NCT01869413 | Bladder Cancer | Tranexamic Acid Placebo | 18 Years - | Ottawa Hospital Research Institute | |
| Robotic Radical Cystectomy Outcomes | NCT04900558 | Bladder Cancer Muscle-Invasive... Oncology Recurrence Surgery | Radical Cystect... | 18 Years - | University of Florence | |
| The Use of Remote Monitoring to Improve Patient-Reported Outcomes and Readmission Rates Following Radical Cystectomy | NCT06397040 | Bladder Cancer Quality of Life | provider monito... participant mon... | 18 Years - | University of Pittsburgh | |
| Neoadjuvant Rapamycin in Patients Undergoing Radical Cystectomy | NCT01827618 | Invasive Bladde... | Rapamycin | 18 Years - | The University of Texas Health Science Center at San Antonio | |
| Intravenous Lidocaine for Cystectomy Procedures | NCT02924480 | Invasive Bladde... | Cystectomy Lidocaine Saline | 18 Years - | CAMC Health System | |
| The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial) | NCT05726786 | Bladder Cancer Interstitial Cy... Painful Bladder... Neurogenic Blad... Hemorrhagic Cys... Endometriosis Bladder Disease | Immunonutrition | 18 Years - | Centre Hospitalier Universitaire Vaudois | |
| Intravenous Lidocaine for Cystectomy Procedures | NCT02924480 | Invasive Bladde... | Cystectomy Lidocaine Saline | 18 Years - | CAMC Health System | |
| Randomized Trial Comparing Robotic and Open Radical Cystectomy | NCT01076387 | Bladder Cancer | open radical cy... robotic-assiste... | 19 Years - | Memorial Sloan Kettering Cancer Center | |
| The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial) | NCT05726786 | Bladder Cancer Interstitial Cy... Painful Bladder... Neurogenic Blad... Hemorrhagic Cys... Endometriosis Bladder Disease | Immunonutrition | 18 Years - | Centre Hospitalier Universitaire Vaudois | |
| Randomized Trial Comparing Robotic and Open Radical Cystectomy | NCT01076387 | Bladder Cancer | open radical cy... robotic-assiste... | 19 Years - | Memorial Sloan Kettering Cancer Center | |
| Biological Effect of Vitamin D in Patients With Urothelial Carcinoma | NCT04197089 | Urothelial Carc... | Vitamin D | 18 Years - 80 Years | Germans Trias i Pujol Hospital | |
| Safety and Efficacy Study of MAGE-A3 + AS-15 in Patients With Muscle-invasive Bladder Cancer After Cystectomy | NCT01435356 | Urinary Bladder... | recMAGE-A3 + AS... Placebo | 18 Years - | European Association of Urology Research Foundation | |
| Trial to Compare Robotically Assisted Radical Cystectomy With Open Radical Cystectomy | NCT03049410 | Bladder Cancer | Intracorporeal ... Open Radical Cy... | 18 Years - | University College, London | |
| Robotic Radical Cystectomy Outcomes | NCT04900558 | Bladder Cancer Muscle-Invasive... Oncology Recurrence Surgery | Radical Cystect... | 18 Years - | University of Florence | |
| Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations | NCT04197986 | Upper Tract Uro... Urothelial Blad... | Infigratinib Placebo | 18 Years - | QED Therapeutics, Inc. | |
| Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer | NCT05312671 | Small Cell Neur... Bladder Cancer Urothelial Carc... | Atezolizumab Carboplatin Cisplatin Etoposide Cystectomy | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Trimodal Prehabilitation for Cystectomy Patients to Enhance Post-operative Care | NCT03347045 | Bladder Cancer Nutrition Aspec... | Trimodal Prehab... No Prehab; ERP ... | 18 Years - | Alberta Health Services, Calgary | |
| EffectiveNess of a Multimodal preHAbilitation Program in patieNts With Bladder canCEr Undergoing Cystectomy | NCT05480735 | Bladder Carcino... | Prehabilitation | 18 Years - | The Netherlands Cancer Institute | |
| Radio-Immunotherapy Before Cystectomy in Locally Advanced Urothelial Carcinoma of the Bladder | NCT03529890 | Urinary Bladder... | Nivolumab Radiation thera... Radical cystect... | 18 Years - | Technical University of Munich | |
| Sirolimus, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Bladder Cancer | NCT01938573 | Recurrent Bladd... Stage II Bladde... Stage III Bladd... Stage IV Bladde... | Cisplatin Gemcitabine Hyd... Sirolimus Cystectomy | 18 Years - | University of Washington | |
| MRI in Clinical Staging and Estimation of Treatment Response in Bladder Cancer | NCT02662166 | Bladder Cancer | MR imaging | 18 Years - 85 Years | Turku University Hospital | |
| Adjuvant Versus Progression-Triggered Gemcitabine Monotherapy for Locally Advanced Bladder Cancer | NCT00146276 | Bladder Cancer Carcinoma, Tran... | gemcitabine | 18 Years - | Association of Urologic Oncology (AUO) | |
| Biological Effect of Vitamin D in Patients With Urothelial Carcinoma | NCT04197089 | Urothelial Carc... | Vitamin D | 18 Years - 80 Years | Germans Trias i Pujol Hospital | |
| Intravenous Lidocaine for Cystectomy Procedures | NCT02924480 | Invasive Bladde... | Cystectomy Lidocaine Saline | 18 Years - | CAMC Health System | |
| Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations | NCT04197986 | Upper Tract Uro... Urothelial Blad... | Infigratinib Placebo | 18 Years - | QED Therapeutics, Inc. | |
| Tranexamic Acid During Cystectomy Trial (TACT) | NCT01869413 | Bladder Cancer | Tranexamic Acid Placebo | 18 Years - | Ottawa Hospital Research Institute | |
| Pediatric Ovarian Tissue Banking - Operative Specimens From Females 0-18 Years of Age | NCT04118712 | Benign Cysts Ov... Cystectomy Torsion Malignant Cysts... | - 18 Years | Ann & Robert H Lurie Children's Hospital of Chicago | ||
| Avelumab as Neoadjuvant Therapy in Subjects With Urothelial Muscle Invasive Bladder Cancers (AURA Trial) | NCT03674424 | Non-metastatic ... | Avelumab cystectomy CG DD-MVAC PG | 18 Years - | Jules Bordet Institute | |
| Sirolimus, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Bladder Cancer | NCT01938573 | Recurrent Bladd... Stage II Bladde... Stage III Bladd... Stage IV Bladde... | Cisplatin Gemcitabine Hyd... Sirolimus Cystectomy | 18 Years - | University of Washington | |
| Patient-Centered Surgical Prehabilitation | NCT05715684 | Bladder Cancer Cystectomy | Exercise Traini... Nutritional Int... | 18 Years - 85 Years | Dana-Farber Cancer Institute | |
| A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer | NCT05483868 | Non-muscle-inva... Muscle-Invasive... | AU-011 AU-011 in Combi... AU-011 in Combi... | 18 Years - | Aura Biosciences | |
| Preoperative Carbohydrate Loading for Enhancing Recovery After Radical Cystectomy | NCT05913245 | Anesthesia Urologic Cancer Surgery | Maltodextrin 12... Water | 18 Years - | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | |
| Radio-Immunotherapy Before Cystectomy in Locally Advanced Urothelial Carcinoma of the Bladder | NCT03529890 | Urinary Bladder... | Nivolumab Radiation thera... Radical cystect... | 18 Years - | Technical University of Munich | |
| Radical Cystectomy Compared With Chemoradiation for Muscle Invasive Bladder Cancer | NCT02716896 | Muscle Invasive... | Radiation and c... Radical cystect... | 18 Years - 89 Years | The University of Texas Health Science Center at San Antonio | |
| The Use of Remote Monitoring to Improve Patient-Reported Outcomes and Readmission Rates Following Radical Cystectomy | NCT06397040 | Bladder Cancer Quality of Life | provider monito... participant mon... | 18 Years - | University of Pittsburgh | |
| EffectiveNess of a Multimodal preHAbilitation Program in patieNts With Bladder canCEr Undergoing Cystectomy | NCT05480735 | Bladder Carcino... | Prehabilitation | 18 Years - | The Netherlands Cancer Institute | |
| Infectious Complications After Cystectomy: A Prospective Observational Study | NCT05153694 | Bladder Cancer Infections Infection, Bact... Infection, Hosp... Infection Wound Urinary Tract I... Urinary Bladder... Urinary Tract D... | Cystectomy | - | Ludwig-Maximilians - University of Munich |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
